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Abstract  Colistin  resistance  can  occur  by  chromosomal  mutations  and  by  acquisition  of
plasmid-carrying  determinants,  mainly  mcr-1.  In  the  recent  years,  we  have  observed  the out-
burst of  this  resistance  gene  in  our  region.  Due  to  the  risk  of  the  rapid  dissemination  of  mcr-1,
this finding  has  worried  and  alerted  different  actors  from  the  health  field  and has  become  one
of the  most  prolific  topics.  Our  review  compiles  available  reports  of well-documented  mcr-
1-positive strains  of  Enterobacteriaceae,  obtained  from  different  samples  in Argentina  and
other countries  of Latin  America.  Furthermore,  it  addresses  the  association  of  mcr-1  with  ESBL
resistance  markers  and  outlines  the platforms  involved  in  their  dissemination.
© 2018  Asociación  Argentina  de Microbiología.  Published  by  Elsevier  España,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Escenario  actual  de  la resistencia  a la  colistina  mediada  por plásmidos  en  América
Latina
Resumen  La  resistencia  a  la  colistina  puede  ocurrir  por  mutaciones  cromosómicas  o  por  la
adquisición de  determinantes  localizados  en  plásmidos,  el principal  es  mcr-1. En  los  últimos
an˜os hemos  observado  la  explosiva  aparición  de  este  gen  de resistencia  en  nuestra  región.
Debido al  riesgo  que  implica  la  rápida  diseminación  de  mcr-1, este  hallazgo  ha  preocupado  y
alertado a  los  diferentes  actores  del  área  de la  salud,  y  se  ha convertido  en  uno  de  los  temas  de
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investigación  más importantes.  La  presente  revisión  compila  los  informes  de aislamientos  por-
tadores de  mcr-1  debidamente  documentados  en  Enterobacteriaceae,  obtenidos  de diferentes
muestras en  Argentina  y  otros  países  de  América  Latina.  Además,  aborda  la  asociación  de  mcr-1
con otros marcadores  de resistencia,  como  las  BLEE,  y  describe  las  plataformas  involucradas  en
su diseminación.
©  2018  Asociación  Argentina  de Microbiología.  Publicado  por  Elsevier  España,  S.L.U.  Este
es un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Polymyxins  (colistin  and polymyxin  B)  are polycationic
peptides,  which  act  by targeting  the negative  charges  in
bacterial  lipopolysaccharide  (LPS),  the complex  lipoglycan
that  makes  up  most  of the gram-negative  outer  membrane.
Colistin  (Polymyxin  E)  is  one of  the  few cationic  antimicro-
bial  peptides  commercialized  in both  human  and  veterinary
medicine.  Since  its  introduction  in  the  1950s,  colistin  (COL)
has  been used  mainly  as  a topical  treatment  in human
medicine  owing to  its  nephrotoxicity  and  neurotoxicity  when
given  systemically.  There  are two  commercially  available
forms:  colistin  sulphate  (CS)  and colistin  methanesulphonate
sodium  (CMS),  the latter  being  less  toxic  than colistin  when
administered  parenterally  and  consequently  being  the most
used  both  in parenteral  and  inhalational  formulations.  In
aqueous  solutions,  CMS  undergoes  in  vivo  conversion9.  On
the  other  hand,  CS  is  the only  form  of COL  approved  in
pig  production  in some  countries  for  the control  of  Enter-
obacteriaceae  infections,  particularly  for  those  caused  by
Escherichia  coli. However,  COL  has  been  massively  used
at  sub-inhibitory  concentrations  as  growth  promoters  for
decades  to  improve  weight  gain  and therefore  to  maximize
feed  conversion  efficiency  in  animal production22.  Notewor-
thy,  the  last  survey  conducted  by  the  World  Organization
for  Animal  Health  (OIE)  in  the year  2012  revealed  that  only
10  countries  reported  the  use  of  COL  as  growth  promoter42.
Interestingly,  in the late  2000s  and  after  decades  of  COL
use  in  swine,  several  studies  began  to  report  a significant
COL  resistance  rate  in  Enterobacteriaceae1,4,23,33,49,55.  The
increasing  incidence  of  infections  caused  by  multidrug  resis-
tant  gram-negative  bacteria,  especially  the ones  caused  by
carbapenemase-producing  bacilli in the last  years,  has  led to
the  use  of  polymyxins  as  one of the last  resort  treatments49.
Until  very  recently,  COL  resistance  occurred  by  chro-
mosomal  mutations  only, and therefore,  this resistance
phenotype  was  spread  exclusively  via clonal  transmission  of
resistant  isolates.  However,  two  years  ago  Liu et  al.  reported
the  emergence  of a plasmid-mediated  colistin  resistance
determinant,  mcr-139. Due  to  the risk  of its  rapid dissem-
ination,  this  finding  has worried  and  alerted  different  actors
from  the  health  field,  becoming  one of  the most  prolific
topics.
Acquired resistance to colistin
Acquired  resistance  to  colistin in Enterobacteriaceae  was
described  many  years  ago45,64,  but  in the last  years  colistin-
resistant  K. pneumoniae  isolates  were  more  frequently
reported  worldwide10,11,32,52,  among  others.  In Latin  Amer-
ica  there  are  reports  from  Brazil,  Ecuador,  Venezuela  and
Colombia18,27,50,56,58.
Acquired  resistance  to  COL in Enterobacteriaceae  was
first  documented  in Argentina  in the  last  years  together  with
the  emergence  of  KPC-producing  isolates,  probably  derived
from  the  use  of  this  antimicrobial  agent  in the  therapy
of  infections  by  these  multidrug-resistant  K.  pneumoniae
isolates.  This  resistance  is believed  to  have  occurred  by
selection  of  resistant  subpopulations  in the epidemic  clone
belonging  to  ST258.  However,  it has also  been  observed
in non  KPC-producing  K. pneumoniae  isolates  probably  as
a result  of  clonal  spread43.  The  last  report  of  the PAHO
(Panamerican  Health  Organization)  from  the year  2015
informed  a COL  resistance  rate  of  10.3%  in K.  pneumoniae
isolates  from  hospitalized  patients  in Argentina,  whereas  in
Escherichia  coli  and Enterobacter  cloacae  the percentage
only  reached 2.1%51.  Similar  results  were  obtained  at the
University  Hospital  José  de  San  Martín,  where  COL  resistance
in  K.  pneumoniae  in the year  2010  was  2%  and  3%,  3.6%,
3.8%,  7%,  12%  and 8%,  respectively,  in the  subsequent  years
(unpublished  results).  With  regard  to  E.  coli  isolates,  COL
resistance  emerged  in the last  two  years,  where  an  impor-
tant  increase  from  0.2%  to  1.3% was  observed,  mostly  as  a
result  of  plasmid-mediated  resistance44.  On the other  hand,
acquired  resistance  to  COL remains  very  low in  Acinetobac-
ter  baumannii  (0.2%)  and  Pseudomonas  aeruginosa  (2.5%)
isolates51.
Chromosomal  resistance: different pathways
Bacteria  often  use  different  strategies  to  protect  them-
selves  from  exposure  to  cationic  antimicrobial  peptides  such
as  colistin.  Such  strategies  include  modifications  of  their
lipopolysaccharides  (LPSs),  which  are involved  in the initial
step  of  interaction  between  polymyxins  and  bacteria8,47,48.
These  alterations  can  be  achieved  by  several  covalent
changes  in lipid  A (also  called  endotoxin  molecule)  of
LPS.  Among  them,  the  cationic  substitution  of  the phos-
phate  group  by  the addition  of 4-amino-4-deoxy-l-arabinose
(L-Ara4N)  and  phosphoethanolamine  (PEtN)  are  the  most
common  LPS modifications.  L-Ara4N  modification  is  more
effective  than  PEtN  modification  because  the  decrease  in
the  net charge leading  to colistin  resistance  is more  effec-
tive. The  synthesis  and transfer  of L-Ara4N  and  PEtN  is
mediated  by  an operon  regulated  by  the  activation  of
two-component  systems  (TCSs).  PmrA/PmrB  is  the  main
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system  contributing  to  polymyxin  resistance  (by  environ-
mental  stimuli,  and  specific  mutations  within  the  TCS),
although  in  some  gram-negative  species  is  known  to  occur
via  PhoP/PhoQ8,48.
Other  modifications  associated  to  chromosomal
polymyxin  resistance  have been  described,  such  as
the  reduction  of  acyl  groups  mediated  by  an  lpxR-like
deacylation  and  hydroxylation  of  lipid  A48.  Moreover,  it
was  reported  that K. pneumoniae  uses  alternative  strate-
gies  such  as  participation  of  an  efflux  pump  or  capsule
formation48.
The plasmid-mediated resistance gene  mcr-1
In 2015,  the  emergence  of a plasmid-mediated  colistin  resis-
tance  marker,  named  mcr-1,  was  reported  in  China39. Since
then, numerous  reports  of  the  mcr-1  gene have been docu-
mented  in  Enterobacteriaceae  cultured  from  food, animals,
environment  and humans  worldwide,  most of  them detected
in  over  20  countries  within  3  months  of  its  first  report8.
The  mcr-1  gene  encodes  a PEtN  transferase  leading  to
the  addition  of  PEtN  to  the lipid  A.  An  in  silico  analy-
sis  of  the  amino  acid  sequence  of  this  protein  revealed
that  it  is  strongly  related  to  enzymes  present  in gram-
negative  bacteria,  some  of  which  are intrinsically  resistant
to  polymyxin8,19,48,52. This  gene was  detected  mainly  in
E.  coli  and  to  a lesser  extent,  in other  bacteria  such  as
K.  pneumoniae. To  date,  several  variants  of  mcr-1  have
been  reported  in the literature  (mcr-1.2  to  mcr-1.8,  and
mcr-1.10)2,20,40,66,69 or  are deposited  in Genbank  (variants
mcr-1.9,  mcr-1.11,  mcr-1.12, and  mcr-1.13).  These  variants
have  one  amino  acid  change  each  and  exhibit  a  similar  effect
on  colistin  resistance  compared  with  mcr-1.
Very recently,  four  additional  mcr  determinants  have
been  reported,  mcr-2, mcr-3, mcr-4  and mcr-5. The  mcr-
2  gene  was  identified  in an  E.  coli  isolated  from  pigs  and
cattle  in  Belgium68.  This  marker  was  also  recovered  from
human  samples  in Switzerland37.  Phylogenetic  analysis  of
mcr-2,  which  was  also  described  as  a  PEtN  transferase,
showed  80.6%  amino  acid  identity  with  mcr-1  and  provided
strong  evidence  that  this protein  may  have  originated  from
Moraxella  catarrhalis68.  The  mcr-3 gene  was  found in E.  coli
isolated  from  pigs in Malaysia,  in a clinical  sample  of  K.
pneumoniae  isolated  from  Thailand,  and  a  clinical  sam-
ple  of  Salmonella  Typhimurium  from  the United  States70.
Sequence  analysis  showed  that  mcr-3  is  closely  related  to
PEtN  from  Aeromonas  spp.  The  mcr-4  gene  was  found  in
Salmonella  Typhimurium  and E. coli  from  human  and  food-
producing  animals  in  Europe13.  MCR-4  has  34.0%,  35.0%  and
49.0%  amino  acid  sequence  identity  to  MCR-1,  MCR-2  and
MCR-3,  respectively.  It has  been  proposed  that  mcr-4  may
have  emerged  from  a  Shewanella  species,  a bacterium  com-
monly  present  in aquatic  niches.  Lastly,  mcr-5  was  initially
found  in  14  Salmonella  Paratyphi  B  dTa+  isolates12. MCR-
5  shares  36.11%  protein  identity  with  MCR-1,  35.29%  with
MCR-2,  34.72%  with  MCR-3  and  33.71%  with  MCR-4.  Sequence
analysis  revealed  that mcr-5  might  have  been transferred
from  the  environmental  rod Cupriavidus  gilardii.
These  genes  have  completely  changed  the scenario  of
colistin  resistance  since  they  have become  a  potential  threat
to  public  health.  In  Argentina  and  other  countries  of  Latin
mcr-1
mcr-5
mcr-1
mcr-1
mcr-1
Figure  1  mcr  distribution  in Latin  America.
America,  mcr-1  occurrence  is currently  low,  however,  it  is
possible  to observe  its  rapid increase  (Table  1).  Moreover,
mcr-5 has  been  recently  found  in a colistin-resistant  E.  coli
isolate  from  Brazil  (NZ  PDMU00000000)  (Fig.  1).
Furthermore,  there  is  a clear  association  between
this  determinant  and the different  genes  encoding  -
lactamases,  particularly  those  from  the  blaCTX-M family.  It is
worth mentioning  that  mcr-1  can be found  in  isolates  col-
lected  not only  from  human  and animal  clinical  samples
but  also  from  different  sources  such as  pigs,  wild  birds,
penguins,  poultry  production  and  environmental  niches
(Table  1).  Among these  isolates,  E.  coli  was  the most com-
mon  species  reported  in Brazil  and  Argentina.
The  coexistence  of mcr-1 and  carbapenem  resistance
determinants  (such  as  KPC-2,  NDM  and  IMP-8  carbapene-
mases)  in human  samples  is  of  great  concern  (Table  1). These
findings  highlight  that  Enterobacteriaceae  isolates  carrying
both  mcr-1 and carbapenemase-encoding  genes  may  emerge
as  a  serious  threat  to  antimicrobial  therapy.
Genetic environment and dissemination of the
mcr  gene
Previous  studies  have  shown  that  mcr  genes  are commonly
located  in self-transferable  plasmids,  which are responsible
for  inter-species  dissemination  worldwide.  Plasmid  incom-
patibility  groups  IncI2,  HI1,  HI2,  P,  X1/X2,  X3/X4,  X4, FI,
FIP  and  FII  have  been  reported  as  carriers  of  the differ-
ent mcr  variants12,14,18,23,26,34,39--41,52,58,68,70.  Furthermore,  a
hybrid plasmid,  identified  as  IncI2/IncFIB  also  harbored  this
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Table  1  mcr-1-positive  isolates  reported  in Latin  America.
Species  (n)  Origin  Year Country  Associated  resistance  (n)  COL  MIC  (g/ml)  Reference
E.  coli  (16)  Chicken  and  pig  2012--2013  Brazil  CTX-M-8  (6),  CTX-M-15  (2),
CTX-M-1  (1),  CMY-2  (1)
1--16  (MIC50 = 8)
a  27,28
E.  coli  (9)  Human  (blood,  urine,  abdomen,
bone,  abscess)
2012--2016  Argentina  CTX-M-14  (2),  CTX-M-2  (1),
CTX-M-15  (1)
8--16  (MIC90 = 8)
b  53
E.  coli  (10)  Human  2016  Argentina  No  datah No  datah  53
E.  coli  (1)  Human  (diabetic  foot)  2016  Brazil  CTX-M-8  >4c  26
E.  coli  (6)  Human  (urine)  2014--2016  Argentina  ESBL,  KPC  4--16d  14,44
E. coli  (1)  Human  (peritoneal  fluid)  2016  Ecuador  CTX-M-55  8a  50
E.  coli  (31)  Healthy  poultry  2013--2016  Argentina  CTX-M-2,  CTX-M-14,  CMY-2,
qnrB,  qnrS
4--32  (MIC50 = 8)
e  21,22
E.  coli  (1)  Human  (urine,  neurogenic
bladder)
2016  Argentina  CTX-M-type  8f  5
E.  coli  (1)  Dog  2014  Argentina  CTX-M-2  8e  57
E.  coli  (1)  Human  (rectal  swab)  2016  Argentina  IMP-8  8f  24
E.  coli  (2)  Human  (urine)  2016  Argentina  CTX-M-2  (1)  4--8e,f  30
E.  coli  (7),
K.  pneumoniae  (1)
Human  (urine,  abdominal,  skin)  2016  Argentina  ESBL  (1)  >4d  46
E.  coli  (83),
K.  pneumoniae  (1),
Citrobacter  amalonaticus  (1)
Human  (mainly  urine,  blood,
abdominal  fluid)
2012--2016  Argentina  CTX-M-type  (36),  pAmpC
(4),  PER  (1),  SHV (1),  KPC
(1),  NDM  (2)g
MIC50 =  8;  MIC90 = 8
b  25,54
E.  coli  (5)  Human  (urine,  abdominal  fluid)  2016  Argentina  ESBL  (2)  ≥4  (MIC90 = 4)
d  7
Salmonella  Typhimurium  (3),
E.  coli  (8),
K.  pneumoniae  (1)
Human  (fecal  matter,  urine,
vaginal  discharge,  blood,
abscess)
2013--2016  Colombia  No  datah >4a  59,60
E.  coli  (8) Food  (chicken  meat)  2016  Brazil  CTX-M-2  (4),  CTX-M-8  (2),
CMY-2  (1)
2--8e  41
E.  coli  (h)  Environment  and  avian
(penguin,  seawater)
2012--2016  Brazil  No  datah No  datah  29
E.  coli  (6) Human  (mainly  urine,  blood,
peritoneal  fluid,  bone)
2016  Brazil  No  datah 4--8f  31
E.  coli  (61)  Healthy  poultry  2015--2016  Brazil  No  datah >8a 6
E.  coli  (5) Wild  birds  (Kelp  gulls)  2012  Argentina  CTX-M-2  (1),  CTX-M-14  (4)  4--8e 36
E.  coli  (1) Penguin  2013  Brazil  CTX-M-1  8a  61
E.  coli  (1) Human  (rectal  swab)  2014  Brazil  KPC-2  4e 16
K.  pneumoniae  (1)  Human  (rectal  swab)  2014  Brazil  KPC-2,  CTX-M-15  4e 17
E.  coli  (2) Human  2015  Brazil  KPC-2  (1),  CTX-M-2  (1)  4--8f  15
K.  pneumoniae  (1)  Human  2016  Brazil  KPC-2  16e  3
Susceptibility to colistin was evaluated by: (a) unspecified method, (b) agar dilution, (c) MicroScan system (Beckman Coulter), (d) Phoenix (Becton, Dickinson), (e) microdilution method,
(f) Vitek-2, (g) NDM was detected in C. amalonaticus, (h) no data described in the Abstract.
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resistance  gene67.  In  South  America  only a  few  reports  iden-
tified  the  plasmids  responsible  for  mcr  spread.  To  date,  only
plasmids  from  incompatibility  groups  X4  and  I2 carry the mcr
gene  in  our  region3,21,41,66. An  initial  analysis  of the  plasmid
backbone  suggests  that  these  elements  are highly  similar  to
those  reported  in  China,  Europe  or  North  America.
A  common  feature  of  mcr-1  variants  is their  genetic  envi-
ronment.  This  gene  is  commonly  adjacent  to  the pap2  gene.
Both  genes  can  be  found  either  surrounded  by  two  copies
of  insertion  sequence  ISApl1,  yielding  a  composite  trans-
poson,  downstream  to  a  single  copy  of  ISApl1  or  in the
absence  of  this  element62.  It has  been  proposed  that  the
presence  or  absence  of  this  IS  correlates  with  the  adaptation
of  mcr-1  to a new  host.  A composite  transposon  indicates
a  recent  acquisition  of  this  marker  whereas  the absence
of  ISApl1  or  the presence  of  a single  copy  suggests  that  it
has  been  already  adapted.  Since  all  three  genetic  environ-
ments  have  been  found  in different  plasmids,  it has  been
hypothesized  that  independent  recombination  events  have
led  to the  adaptation  of  the mcr-pap2  segment  to  specific
incompatibility  groups,  which are in turn  responsible  for
dissemination  of  polymyxin  resistance.  However,  a recent
report  demonstrated  that  the  composite  transposon  Tn6330,
which  has  two  ISApl1  surrounding  mcr-1, can  translocate  to
other  plasmids35.  Therefore,  the possibility  of a wider  dis-
semination  to  plasmids  from  other  incompatibility  groups
should  be considered.  It  is  worth  noting  that  a study  on
ISApl1  function  showed  that when this  sequence  is  active
it  is  detrimental  to  the host,  which  leads  to  its loss63.  Indi-
rectly,  this  phenomenon  might  control  the  dissemination  of
mcr-1.
In 2016  Xavier  et  al.  identified  the first  mcr-2  gene  in
an  IncX4  plasmid  from  bovine  and  porcine  E.  coli68. Fur-
ther  analysis  showed  that  mcr-2  is  located  at  the same
site  than  mcr-1 when found  in the  IncX4  plasmid.  Despite
this  fact,  mcr-2  was  found  surrounded  by  two  copies of
the  insertion  sequence  IS1595  allowing  this  DNA  to  gen-
erate  circular  intermediates65.  This  finding  reveals  the
potentiality  of  mcr-2  to  disseminate  to  other  plasmids  and
therefore,  to  other  organisms.  More  recently,  novel  mcr
determinants  have  been  described.  The  mcr-3  gene  has
been  found  in  plasmids  from  the  IncHI2  group  harbored
in  Enterobactericeae  as  well  as  in the  chromosome  of
Aeromonas  veronii38,70. When  located  in plasmids,  mcr-3  is
adjacent  to  the  truncated  transposon  element  TnAs270,  a
mobile  element  probably  responsible  for its  spread.  On the
other  hand,  mcr-4 and  mcr-5  genes  were  found  in small
non-self-transferable  plasmids  from the ColE  family12,13.
Furthermore,  the  mcr-5  gene  is  located  in a  Tn3-family
transposon.
Concluding remarks
The data  summarized  herein  show  the rapid  spread  of  mcr-1
in  Latin  America.  To  the  best  of our  knowledge,  mcr-2, mcr-
3  and  mcr-4  determinants  have  not been  found in our  region
yet.
The  mcr-1  marker  has  been found  in  a  wide  variety  of  eco-
logical  niches,  which  represents  a troublesome  scenario  for
public  health.  In the absence  of  new  antimicrobial  agents
against  multidrug-resistant  gram-negative  pathogens,  the
effect  of  plasmid-mediated  colistin  resistance  on  human
health  should  not be underestimated.
There  is  an urgent  need  for  surveillance  and  molecu-
lar  epidemiological  studies  in both human  and veterinary
medicine  addressing  the  dissemination  of  mcr-1 among bac-
terial  isolates.  The  fact  that most  mcr  genes  were  found
in  other  regions  raises  the question  of  whether  a  unique
variant  is  locally  disseminated  or  if the other  variants  were
accurately  sought.
Furthermore,  we  suggest  a re-evaluation  of  the antimi-
crobial  agents  used in  animal  feeding  in order  to  reduce  the
potential  risk  to  pandrug  resistance.
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